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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S336risk of injury. Thereby, the present ﬁnding could indicate that GJH may
be an important risk factor for knee injuries and later development of
OA.
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KNEE EXTENSOR MUSCLE WEAKNESS INCREASES THE RISK OF KNEE
OSTEOARTHRITIS. A SYSTEMATIC REVIEW AND META-ANALYSIS
B.E. Øiestad y, C.B. Juhl z, I. Eizen x, J.B. Thorlund z. yNorwegian research
center for Active Rehabilitation (NAR), Oslo Univ. Hosp., Oslo, Norway;
zRes. Unit for Musculoskeletal Function and Physiotherapy, Univ. of
Southern Denmark, Odense, Denmark; xUniv. Hosp. Oslo, Dept. of
Orthopædics, Oslo, Norway
Purpose: Previous studies including systematic reviews have suggested
that knee extensor muscle weakness is a risk factor for the development
of knee osteoarthritis (OA). However, systematic reviews have not
aggregated the reported data into a meta-analysis. The aim of this study
was to estimate the impact of knee extensor muscle weakness on the
risk of knee OA.
Methods: A systematic review and meta-analysis was performed with
literature searches in Medline, SportsDiscus, EMBASE, CINAHL, and
AMED, all up to September 2013. Furthermore reference lists and sys-
tematic reviews on the topic were scrutinized for additional relevant
studies. No restriction on language or publication year was made. Eli-
gible studies had to include participants with no radiographic or
symptomatic knee OA at baseline, and have a follow-up time of mini-
mum 2 years. Studies had to include a measure of knee extensor muscle
strength. Participants were classiﬁed as having knee extensor muscle
weakness if they belonged to the lowest tertile or less in muscle
strength or deﬁned from a leg symmetry index (LSI). If more than one
muscle strength outcome or knee OA deﬁnition were reported, a pre-
deﬁned hierarchy for extracting data was used. The hierarchy was: 1)
Symptomatic radiographic knee OA for the whole knee, 2) Radiographic
knee OA, and 3) Self-reported OA. Peak knee extensor muscle strength
per kg body weight was preferred as measure of muscle strength;
secondly average knee peak torque was extracted. Odds ratio (OR) for
knee OA at follow-upwas estimated in the included trials and combined
using a random effects model. Stratiﬁed analysis for men and women
were performed.
Results: A total of 1000 studies were identiﬁed thorough the literature
searches. After review, four cohort studies with a follow-up time
between 2.5 and 14 years were included. A total of 5102 participants
(3325 men and 1777 women) were included in the ﬁnal analysis. The
studies included different groups of participants; middle-aged indi-
viduals with and without previous knee injury, elderly individuals
without previous knee injury, as well as younger anterior cruciate lig-
ament reconstructed (ACLR) individuals. Weakmuscle strengthwas in 2
trials deﬁned as being in the lowest tertile, when assessing the iso-
kinetic knee extensor muscle strength. In one trial low muscle strength
was deﬁned as having a leg symmetry index of less than 80% (muscle
strength in the affected leg was less than 80% of the muscle strength in
the non-affected leg). Finally in one trial only data on the differences in
muscle strength between patients with and without OA was available.
Overall the meta-analysis showed an increased risk of knee OA in par-
ticipants with knee extensor muscle weakness (OR 1.54 95%CI 1.28,
1.88; I2 ¼ 14.5%). Three trials reported separate data for men and
women and subgroup analysis showed increased risk in men (OR 1.43
95%CI 1.14, 1.78; I2 ¼ 0%) and women (OR 1.79 95%CI 1.37, 2.31; I2 ¼
3.3%), but differences in risk between men and women did not reach
statistical signiﬁcance (P¼0.200).
Conclusions: Knee extensor weakness increased the risk of having knee
OA at follow-up. Even though not statistically signiﬁcant, the analysis
indicated that weak knee extensor strength seems to be a stronger risk
factor for OA in women than in men.
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RISK FACTORS FOR MAGNETIC RESONANCE IMAGING DIAGNOSED
PATELLAR TENDINOPATHY IN COMMUNITY-BASED MIDDLE-AGED
WOMEN
J. Toppi, J. Fairley, F. Cicuttini, J. Cook, S. Davis, R. Bell, F. Hanna,
Y. Wang. Monash Univ., Melbourne, AustraliaPurpose: Patellar tendinopathy, a condition that causes activity-related
anterior knee pain, has diagnostic magnetic resonance imaging (MRI)
features. The aim of this study was to examine the prevalence and risk
factors for MRI-diagnosed patellar tendinopathy in community-based
middle-aged women.
Methods: 176 women, aged 40-67 years, with no signiﬁcant knee pain
or injury underwent knee MRI. An MRI diagnosis of patellar tendin-
opathy was made if an area of increased signal intensity was seen in the
proximal inferior patellar tendon region on at least 2 adjacent slices on
both T1- and T2-weighted images. The cross-sectional area of vastus
medialis was measured fromMRI. Height and weight were measured to
calculate body mass index (BMI). Physical activity was assessed using a
questionnaire. Serum concentrations of C-reactive protein, androste-
nedione, dehydroepiandrosterone sulphate, testosterone, and sex hor-
mone binding globulin (SHBG) were measured.
Results: The prevalence of MRI-diagnosed patellar tendinopathy was
30.1%. Higher levels of physical activity (odds ratio 1.65, 95% CI 1.09-
2.51) and greater vastus medialis cross-sectional area (odds ratio 1.22,
95% CI 1.04-1.43) were associated with increased prevalence of patellar
tendinopathy, independent of age and BMI. There were no associations
with C-reactive protein, the sex steroids or SHBG.
Conclusion: In community-based middle-aged women MRI-diag-
nosed patellar tendinopathy is common, with higher levels of
physical activity and greater vastus medialis size being risk factors.
The ﬁndings highlight the importance of mechanical factors in the
pathogenesis of patellar tendinopathy. Further work is needed to
determine the contribution of patellar tendinopathy to knee pain
and function.OA: cartilage and bone
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PROGRANULIN A CHONDROPROTECTIVE GROWTH FACTOR IN THE
PATHOGENESIS OF OSTEOARTHEITIS
B.S. Richbourgh, C. Liu, Y. Zhao, B. Liu. NYU Sch. of Med., New York, NY,
USA
Purpose: The objective of this study is to determine the role of PGRN in
human chondrocyte metabolism in vitro and in the course of OA pro-
gression in vivo, as well as the molecular mechanisms involved.
Method: Human chondrocytes and cartilage explants were isolated
from OA patients. The isolated chondrocytes were cultured in the
presence of TNF-a, PGRN, or both. Three days after treatment, cells and
explants were collected and analyzed for anabolic and catabolic mark-
ers. Approaches for evaluating cartilage metabolism, including Safra-
nin-O staining, immunohistochemistry, ELISA and Western blotting,
were performed. A destabilization of medial meniscus (DMM) surgically
induced murine model was generated with both wildtype and PGRN
deﬁcient mice. For testing the effect of recombinant PGRN in severe OA
the ACL model was used. OA severity was evaluated using histological
assay (e.g. Safranin-O staining), degradation of cartilage extracellular
matrix molecules, and osteophyte formation.
Results: TNF-a dramatically reduced the levels of anabolic markers and
enhanced the levels of catabolic markers including MMP13, ADAMTS-5,
iNOS and COX-2, (Figure.1) while this alteration was largely abolished
by additional treatment of PGRN, suggesting PGRNs protective role
against human cartilage degeneration. Our results also demonstrated
that PGRN greatly stimulates anabolic makers, including Aggrecan and
Collagen type 2. (Figure.2). Histological analysis of cartilage isolated
from DMM model revealed (Figure.3) signiﬁcantly increased cartilage
degradation in PRGN-/- mice relative toWT. Safranin O staining showed
little or no proteoglycans in PRGN -/- mice along with signiﬁcantly
increased serum COMP fragment levels. Intra-articular injection of
PRGN signiﬁcantly reduced the degeneration of cartilage in surgically
induced ACL model in WT mice, reﬂected by histological analysis of
cartilage. In the ACL model 4 weeks-post surgery, PRGN treated mice
retained cartilage integrity and showed little or no degradation of car-
tilage matrix in comparison to highly degraded cartilage of non-treated
mice. Collectively, PRGN deﬁcient mice develop more severe OA
whereas treatment with PRGNmarkedly delays the progression of OA in
WT mice.
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S337Conclusion: PGRN plays a chondroprotective role in the pathogenesis
of OA, through a) inhibiting TNFa-induced catabolic and b) activating
anabolic metabolism as a novel chondrogenic growth factor.
Fig. 3. The protective role of PRGN in surgically-induced osteoarthritis A)
PGRN-/-mice showed elevated degradation of cartilage in DMM model. B)
Intra-articular injection of PRGN reduces the loss of proteoglycan in sur-
gically induced OA.
Figure 1. PGRN effectively prevents the loss of cartilage by TNF-a. Total
RNA was extracted and real-time polymerase chain reaction (PCR) was
performed using a sequence-speciﬁc probe and primers for MMP13 (a),
RUNX2 (b), COX-2 (c) and iNOS (d). Each was tested under three con-
ditions (control, TNF-a and TNF-awith PGRN). Our results demonstrated a
drastic decrease in all metabolic levels with the induction of PGRN (Figure
4.a, b, c, d).
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TNFa IS A CRITICAL MEDIATOR OF SYNOVIAL HYPERPLASIA AND
OSTEOPHYTE FORMATION IN HIGH FAT-FED MICE
R.A. Mooney, D. Hamada, R. Maynard, S.L. Kates, M.J. Zuscik. Univ. of
Rochester Med. Ctr., Rochester, NY, USA
Purpose: Obesity and associated type 2 diabetes are important risk fac-
tors for osteoarthritis (OA). A critical hallmark of themetabolic disease ofdiabetes is a low-grade chronic inﬂammation. Evidence indicates that the
proinﬂammatory cytokine TNFa plays an important role inmediating the
metabolic dysfunction in this state. Inﬂammation is now also recognized
to be a contributing factor in the pathogenesis of osteoarthritis. Here we
use human ﬁbroblast-like synoviocytes (FLS) and mouse models to test
thehypothesis that TNFaplays an important role inmediating theadverse
effects of obesity and type 2 diabetes on two aspects of OA progression:
synovial hyperplasia and osteophyte formation.
Methods: Animals: Male C57BL/6J (wild type) mice were bred from
existing colonies and age matched to TNFa-/- mice (Jackson Labs). Mice
were placed on high-fat (HF, 60% kcal, D12492) or low-fat (LF, 10% kcal,
D12450B) diets at 5 weeks of age (Open Source Diets, Research Diets).
Mice were continued on their diets for 24 weeks before sacriﬁce and
harvest. Histology: Following sacriﬁce, knee joints were isolated and
formalin ﬁxed, decalciﬁed, and embedded in parafﬁn. Sagittal sections
were stained with Alcian blue-hematoxylin before assessment. Synovial
samples: Human FLSs were isolated from the synovial tissues of OA
patients undergoing total knee arthroplasty. FLSs were serum-starved
overnight prior to 24h treatment with cytokine and insulin. Total RNA
was extracted from FLSs and gene expression quantitated by qRT-PCR.
Results: Immunohistochemistry demonstrated that while TNFa and
BMP2 were not detected in the synovium of LF fed mice, there was
strong synovial expression of both genes in mice fed the HF diet. This
increased expression was associated with synovial hyperplasia and
increased formation of osteophytes. To investigate these potential
mediators of HF diet-associated osteoarthritis more directly, the
response of human FLSs to TNFa was examined. In response to TNFa
treatment, expression of BMP2 and TNFa was increased 6 and 40-fold,
respectively, as measured by qRT-PCR. The latter result suggests a feed
forward ampliﬁcation of TNFa. Importantly, insulin inhibited the effects
of TNFa on BMP2 expression by approximately 50%. To assess the in vivo
effect of TNFa, TNFa knockout mice were placed on the HF and LF diets
for 24weeks. As expected, absence of TNFa blunted theweight gain and
the glucose intolerance that is observed in HF diet fed mice. In LF fed
TNFa-/- mice, osteophyte numbers and synovial hyperplasia were
modestly increased above baseline, suggesting a role for TNFa in joint
maintenance under control conditions. Importantly, the increase in
osteophyte number and synovial hyperplasia present in HF-fed wild
type mice was completely absent in HF TNFa-/- mice, supporting a
pathogenic role for TNFa in osteoarthritis during HF diet consumption,
obesity, and type 2 diabetes/systemic inﬂammation.
Conclusions: TNFa plays an important role in the weight gain and
metabolic dysregulation of HF diet-associated obesity and type 2 dia-
betes. TNFa also promotes expression of osteoarthritis-associated
cytokines by FLSs, which can be reversed by insulin treatment, sug-
gesting a protective role for insulin in synovial joints. Finally, the
TNFa-/- mouse model conﬁrms the critical role of TNFa in the patho-
genesis of synovial hyperplasia and osteophyte formation in HF-fed,
obese and diabetic mice.
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SHORT BUT NOT LONG TERM SCLEROSTIN INHIBITION WORSENS
POST-TRAUMATIC OSTEOARTHRITIS IN MICE
B.Y. Chan, S. Zaki, S. Smith, M. Smith, C.B. Little. Raymond Purves Res.
Labs, Kolling Inst. of Med. Res., The Univ. of Sydney, St Leonards, Australia
Purpose: Sclerostin (SOST) and dikkopf-1 (DKK1) are secreted proteins
that inhibitWnt signaling. IncreasedWnt-b-catenin activity is implicated
in cartilage degradation in osteoarthritis (OA), at the same time driving
increased bone formation (subchondral thickening, osteophytes) that
typiﬁes OA. This suggests that increasing SOST/DKK1 may be protective
while inhibiting these Wnt antagonists may worsen OA cartilage and
bone pathology. A recent report found that over-expression of DKK1 in
chondrocytes did indeed reduce cartilage and bone pathology in post-
traumatic (pt)OA in mice, however in another study systemic SOST
inhibition did not alter ptOA cartilage erosion in rats. Whether these
different outcomes relate to the inhibitor targeted and their systemic
versus cell-speciﬁc regulation, or the species and ptOA model used is
unclear. The present study examined whether systemic inhibition of
SOST changed ptOA pathology in mice induced by the same meniscal
destabilization (DMM) model as in the DKK1 over-expression study.
Methods: Forty-eight 10-week male C57BL6 mice had unilateral DMM
surgery andwere randomly assigned to receive 20mg/kg of anti-SOSTor
control IgG antibody (provided by Eli-Lilly) subcutaneously twice
weekly: from the day of surgery and sacriﬁced at 4 (group 1) or 8 (group
